ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

REGRANEX
Pressure/neuropathic ulcers
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

REGRANEX Rx

Generic Name and Formulations:
Becaplermin 0.01%; gel; contains parabens, m-cresol.

Company:
Healthpoint Biotherapeutics

Therapeutic Use:

Indications for REGRANEX:

Adjunct in the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and have an adequate blood supply.

Adult:

≥16yrs: Apply once daily until complete healing has occurred. Measure size of ulcer and adjust at 1–2 week intervals. Calculate amount of gel needed based on ulcer size and product tube size. Squeeze calculated length of gel from tube onto clean measuring surface (eg, wax paper). Spread gel over entire ulcer to thickness of about 1/16 inch. Cover with saline dressing for about 12 hrs. Remove dressing and rinse. Replace with clean saline dressing (no gel). Reevaluate if ulcer does not decrease in size by about 30% after 10 weeks, or if complete healing has not occurred after 20 weeks.
To calculate amount of gel in centimeters: If using the 15g tube: Length of gel (in cm) to be applied daily = wound area (length x width in cm2) ÷ 4. If using the 2g tube: Length of gel (in cm) to be applied daily = wound area (length x width in cm2) ÷ 2.

Children:

<16yrs: not recommended.

Contraindications:

Neoplasm(s) at application site.

Warnings/Precautions:

Systemic malignancies (increased death rate with ≥3 tubes of becaplermin gel treatment). Not for use in wounds that close by primary intention. Pregnancy (Cat.C). Nursing mothers.

Pharmacological Class:

Growth factor.

Adverse Reactions:

Erythematous rash.

How Supplied:

Gel—2g, 15g

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs